TXG
10x Genomics·NASDAQ
--
--(--)
--
--(--)
5.82 / 10
Netural
Analyst sentiment is split: two Strong Buys and two Neutrals, yielding a neutral outlook. Fund‑flow score is 7.69 (good), with small‑cap inflows positive but medium‑large blocks negative. Overall money flow is robust despite mixed analyst views.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-20
InstitutionUBS
Times predicted4
Historical Win Rate50.0%
What is the analyst consensus for TXG?
- TXG holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.82/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
